| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.29 | 1e-05 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | -0.17 | 2e-05 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.15 | 2e-05 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | 0.17 | 3e-05 |
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | 0.2 | 4e-05 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.21 | 5e-05 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | -0.14 | 9e-05 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | -0.16 | 0.0001 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0001 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.25 | 0.0001 |